Skip to main content
Top
Published in: Archives of Osteoporosis 1-2/2012

01-12-2012 | Short Communication

Gender differences in osteoporosis screening: retrospective analysis

Authors: Khaled Alswat, Suzanne Myers Adler

Published in: Archives of Osteoporosis | Issue 1-2/2012

Login to get access

Abstract

Introduction

Osteoporosis is a common disease affecting 20 % of all men. It accounts for more than 1.5 million fractures yearly in the USA. Up to 20 % of patients who sustain hip fractures die within the first 12 months from related complications. The Endocrine Society recommends screening all men 70 years or older regardless of risk factors. There are little data comparing gender-specific osteoporosis screening rates. The aim of the study is to identify any gender difference in osteoporosis screening.

Methods

We conducted a retrospective study to determine the screening rates for osteoporosis in males and females in our Division of Internal Medicine, university-based outpatient clinic (UBC). Males aged 70–75 years and females aged 65–70 years with a primary care physician (PCP) at our UBC, who have had at least one routine health maintenance exam (HME) since 2002, were included.

Results

A total of 8,262 patients who met the age criteria were identified: 3,255 (39.4 %) males and 5,007 (60.6 %) females. Of the 3,255 male patients, 342 patients had their PCP at our UBC and had at least one HME; of those, 63 patients had DXA performed for an osteoporosis screening rate of 18.4 %. Of the 5,007 female patients, 668 patients had their PCP at our UBC and had at least one HME; of those, 402 patients had DXA performed for an osteoporosis screening rate of 60 %.

Conclusion

Males are screened less frequently although they have a comparable prevalence of osteoporosis.
Literature
1.
go back to reference Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761–1768PubMedCrossRef Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761–1768PubMedCrossRef
2.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRef
3.
go back to reference Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733PubMedCrossRef Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733PubMedCrossRef
4.
go back to reference Forsén L, Sogaard AJ, Meyer HE, Edna T, Kopjar B (1999) Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int 10:73–78PubMedCrossRef Forsén L, Sogaard AJ, Meyer HE, Edna T, Kopjar B (1999) Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int 10:73–78PubMedCrossRef
5.
go back to reference Sernbo I, Johnell O (1993) Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int 3:148–153PubMedCrossRef Sernbo I, Johnell O (1993) Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int 3:148–153PubMedCrossRef
6.
go back to reference Adams AL, Shi J, Takayanagi M, Dell RM, Funahashi TT, Jacobsen SJ (2012) Ten-year hip fracture incidence rate trends in a large California population, 1997–2006. Osteoporos Int. doi: 10.1007/s00198-012-1938-5 Adams AL, Shi J, Takayanagi M, Dell RM, Funahashi TT, Jacobsen SJ (2012) Ten-year hip fracture incidence rate trends in a large California population, 1997–2006. Osteoporos Int. doi: 10.1007/s00198-012-1938-5
7.
go back to reference Adler RA (2006) The need for increasing awareness of osteoporosis in men. Clin Cornerstone 8:S7–S13PubMedCrossRef Adler RA (2006) The need for increasing awareness of osteoporosis in men. Clin Cornerstone 8:S7–S13PubMedCrossRef
8.
go back to reference Cohen K, Maier D (2008) Osteoporosis: evaluation of screening patterns in a primary-care group practice. J Clin Densitom 11(4):498–502PubMedCrossRef Cohen K, Maier D (2008) Osteoporosis: evaluation of screening patterns in a primary-care group practice. J Clin Densitom 11(4):498–502PubMedCrossRef
9.
go back to reference Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS (2012) Osteoporosis in men: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802–1822PubMedCrossRef Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS (2012) Osteoporosis in men: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802–1822PubMedCrossRef
10.
go back to reference Duyvendak M, Naunton M, Atthobari J, van den Berg PB, Brouwers JR (2007) Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001–2005. Osteoporos Int 18(10):1429–1433PubMedCrossRef Duyvendak M, Naunton M, Atthobari J, van den Berg PB, Brouwers JR (2007) Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001–2005. Osteoporos Int 18(10):1429–1433PubMedCrossRef
11.
go back to reference Jennifer Elston L, Deneil K, Peterson EL, McCarthy BD, Weiss TW, Ya-Ting C, Muma BK (2007) Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 22(3):346–351CrossRef Jennifer Elston L, Deneil K, Peterson EL, McCarthy BD, Weiss TW, Ya-Ting C, Muma BK (2007) Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 22(3):346–351CrossRef
12.
go back to reference Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809PubMedCrossRef Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809PubMedCrossRef
13.
go back to reference Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJ, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD (2009) Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 20:507–518PubMedCrossRef Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJ, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD (2009) Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 20:507–518PubMedCrossRef
Metadata
Title
Gender differences in osteoporosis screening: retrospective analysis
Authors
Khaled Alswat
Suzanne Myers Adler
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Archives of Osteoporosis / Issue 1-2/2012
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-012-0113-0

Other articles of this Issue 1-2/2012

Archives of Osteoporosis 1-2/2012 Go to the issue